Cargando…
Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
Inhibition of vascular endothelial growth factor (VEGF) in retinopathy of prematurity (ROP) raises concerns for premature infants because VEGF is essential for retinovascular development as well as neuronal and glial health. This study tested the hypothesis that endothelial cell-specific knockdown o...
Autores principales: | Simmons, Aaron B., Bretz, Colin A., Wang, Haibo, Kunz, Eric, Hajj, Kassem, Kennedy, Carson, Yang, Zhihong, Suwanmanee, Thipparat, Kafri, Tal, Hartnett, M. Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203654/ https://www.ncbi.nlm.nih.gov/pubmed/29730824 http://dx.doi.org/10.1007/s10456-018-9618-5 |
Ejemplares similares
-
Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
por: Simmons, Aaron B., et al.
Publicado: (2018) -
Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms
por: Becker, Silke, et al.
Publicado: (2018) -
RNA-Seq Provides Insights into VEGF-Induced Signaling in Human Retinal Microvascular Endothelial Cells: Implications in Retinopathy of Prematurity
por: Ramshekar, Aniket, et al.
Publicado: (2022) -
Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery
por: Suwanmanee, Thipparat, et al.
Publicado: (2017) -
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization.
por: Hu, Peirong, et al.
Publicado: (2018)